Drug Interactions between CellCept and Nexium
This report displays the potential drug interactions for the following 2 drugs:
- CellCept (mycophenolate mofetil)
- Nexium (esomeprazole)
Interactions between your drugs
mycophenolate mofetil esomeprazole
Applies to: CellCept (mycophenolate mofetil) and Nexium (esomeprazole)
Talk to your doctor before using mycophenolate mofetil together with esomeprazole. Combining these medications may reduce the blood levels of mycophenolate mofetil. Whether this will decrease the effectiveness of mycophenolate mofetil in the treatment of your condition is unknown. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
Applies to: Nexium (esomeprazole)
Food may interfere with the absorption of esomeprazole. Esomeprazole should be taken at least one hour before meals and at the same time every day. When esomeprazole is given to patients receiving continuous enteral nutrition (tube feedings), the tube feeding should be interrupted for at least 1 hour before and 1 hour after the dose of esomeprazole. This will make it easier for your body to absorb the medication. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|